Author name: PRNewswire

RMJAX, RMHIX, RMHVX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Easterly ROCMuni High Income Municipal Bond Fund Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit

NEW YORK, July 27, 2025 /PRNewswire/ — Bronstein, Gewirtz & Grossman, LLC, a nationally recognized law firm, notifies investors that a class action lawsuit has been filed against Easterly ROCMuni High Income Municipal Bond Fund f/k/a Principal Street High Income Municipal Fund (“Easterly ROCMuni Fund” or “the Company”) (NASDAQ: RMJAX, RMHIX, RMHVX) and certain of its

RMJAX, RMHIX, RMHVX INVESTOR ALERT: Bronstein, Gewirtz & Grossman LLC Announces that Easterly ROCMuni High Income Municipal Bond Fund Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit Read Post »

Press

CNC INVESTOR ALERT: Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit

SAN DIEGO, July 27, 2025 /PRNewswire/ — The law firm of Robbins Geller Rudman & Dowd LLP announces that the Centene class action lawsuit – captioned Lunstrum v. Centene Corporation, No. 25-cv-05659 (S.D.N.Y.) – seeks to represent purchasers or acquirers of Centene Corporation (NYSE: CNC) securities and charges Centene and certain of Centene’s executives with violations

CNC INVESTOR ALERT: Centene Corporation Investors with Substantial Losses Have Opportunity to Lead Securities Class Action Lawsuit Read Post »

Press
LuminEyes Light Therapy Device

Breakthrough in Light Therapy: KouShiCare utilizes DWV™LLLT Technology to Treat Dry Eyes

HONG KONG, July 27, 2025 /PRNewswire/ — KouShiCare, a leading innovator in healthcare technology, is proud to announce a groundbreaking advancement in the treatment of dry eye disease. The company’s latest device harnesses the power of DWV™ Low-Level Laser Therapy (LLLT) technology, marking a significant step forward in light-based ocular care. Approximately 344 million people

Breakthrough in Light Therapy: KouShiCare utilizes DWV™LLLT Technology to Treat Dry Eyes Read Post »

Press

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE

TORONTO, July 27, 2025 /PRNewswire/ — The Alzheimer’s Association® will present 10 scientific awards at the Alzheimer’s Association International Conference® 2025 (AAIC®), recognizing researchers for their expertise, noteworthy achievements and innovative contributions to the field of Alzheimer’s disease and dementia science. “The Alzheimer’s Association envisions a world without Alzheimer’s and all other dementia, and these leaders

TEN RESEARCHERS HONORED AT ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE Read Post »

Press

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: FRED AND BARBARA ERB FAMILY FOUNDATION HONORED FOR PHILANTHROPIC LEADERSHIP IN ALZHEIMER’S RESEARCH

TORONTO, July 27, 2025 /PRNewswire/ — The Alzheimer’s Association® honored the Fred and Barbara Erb Family Foundation with the Jerome H. Stone Philanthropy Award for Alzheimer’s Research at the Alzheimer’s Association International Conference ® 2025 (AAIC®) for their deep and unwavering contributions to advancing progress in Alzheimer’s science. Fred A. Erb grew his family’s firm

FROM THE ALZHEIMER’S ASSOCIATION INTERNATIONAL CONFERENCE 2025: FRED AND BARBARA ERB FAMILY FOUNDATION HONORED FOR PHILANTHROPIC LEADERSHIP IN ALZHEIMER’S RESEARCH Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Ultragenyx Pharmaceutical Inc. (“Ultragenyx” or the “Company”) (NASDAQ: RARE).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Ultragenyx and certain of its officers and/or directors have engaged in securities fraud

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Ultragenyx Pharmaceutical Inc. – RARE Read Post »

Press

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation – NEOG

NEW YORK, July 27, 2025 /PRNewswire/ — Pomerantz LLP is investigating claims on behalf of investors of Neogen Corporation (“Neogen” or the “Company”) (NASDAQ: NEOG).  Such investors are advised to contact Danielle Peyton at [email protected] or 646-581-9980, ext. 7980.   The investigation concerns whether Neogen and certain of its officers and/or directors have engaged in securities fraud or other

INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of Neogen Corporation – NEOG Read Post »

Press
Scroll to Top